Apogee Therapeutics (APGE) Tax Provisions (2024 - 2026)
Apogee Therapeutics' (APGE) quarterly Tax Provisions came in at $79000.0 in Q1 2026, down 4.82% year-on-year from $83000.0 in Q1 2025, and up 100.15% on a QoQ basis from -$53.9 million in Q4 2025.
Apogee Therapeutics (APGE) Tax Provisions (2024 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 3 years of Tax Provisions data on file, last reported at $79000.0 in Q1 2026.
- On a quarterly basis, Tax Provisions fell 4.82% year-over-year to $79000.0 in Q1 2026; TTM through Mar 2026 was -$53.7 million, a 11593.46% decrease from a year earlier, with the FY2025 full-year figure at -$53.7 million, down 9802.03% from the prior year.
- Tax Provisions for Q1 2026 stood at $79000.0, up from -$53.9 million in the prior quarter.
- Over the last five years, Tax Provisions for APGE reached as high as $83000.0 in Q1 2025 and fell as low as -$53.9 million in Q4 2025.
- Historically, Tax Provisions has averaged -$9.0 million across 3 years, with a median of $66500.0 in 2025.
- Across the five-year window, Tax Provisions slumped 9841.88% in 2025 and decreased 4.82% in 2026, its largest moves.
- Year by year, Tax Provisions stood at -$542000.0 in 2024, then slumped by 9841.88% to -$53.9 million in 2025, then jumped by 100.15% to $79000.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $79000.0 in Q1 2026, -$53.9 million in Q4 2025, and $61000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Apogee Therapeutics | 9.36 Bn | 8.30 Bn | - | 79,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | -53.89 Mn |
| Sep 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Mar 31, 2025 | 83,000.00 |
| Dec 31, 2024 | -542,000.00 |